Liminatus Pharma Inc (LIMN) Stock Price, Quote, News & History

LIMNNASDAQ
$3.48
0.092.65%
At close: Sep 18, 5:00 PM EST
$3.40
-0.08-2.3%
After Hours: 5:40 PM EST

Liminatus Pharma (LIMN) Stock Price, Quote, News & History | Benzinga

Loading...

Key Statistics

Open
$3.43
Close
$3.48
Volume / Avg.
23.26K / 673.35K
Day Range
$3.41 - $3.68
52 Wk Range
3.29 - 141.50
Market Cap
$4.57M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
35
Short Interest
8.83%
Days to Cover
1.34

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-3.97M
Investing Cash Flow (TTM)
-13.11K
Financing Cash Flow (TTM)
5.66M
Free Cash Flow (TTM)
-3.99M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
1.68M

Valuation Metrics

Enterprise Value
$3.10M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
15.19
Earnings Yield % (TTM)
-705.88%
Earnings Yield % (FWD)
-
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$0.22

Company Debt

Total Debt
$1.44M
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$3.02M
Debt to Equity
4.80
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
$0

Key Statistics

Open
$3.43
Close
$3.48
Volume / Avg.
23.26K / 673.35K
Day Range
$3.41 - $3.68
52 Wk Range
3.29 - 141.50
Market Cap
$4.57M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
35
Short Interest
8.83%
Days to Cover
1.34

About

Sector
Health Care
Industry
Biotechnology
Liminatus Pharma Inc is a clinical-stage biopharmaceutical company engaged in developing cancer therapies and treatments. The company is developing a next generation CD47 immune checkpoint inhibitor that enables cancer cells to evade detection by the...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Liminatus Pharma (LIMN) stock?

A

You can purchase shares of Liminatus Pharma (NASDAQ:LIMN) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Liminatus Pharma (LIMN) competitors?

Q

What is the forecast, or price target, for Liminatus Pharma (LIMN) stock?

A

There is no analysis for Liminatus Pharma to provide a consensus price target.

Q

What is the current price for Liminatus Pharma (LIMN)?

A

The stock price for Liminatus Pharma (NASDAQ: LIMN) is $3.4 last updated September 18, 2026 at 5:40 PM EDT.

Q

Does Liminatus Pharma (LIMN) pay a dividend?

A

There are no upcoming dividends for Liminatus Pharma.

Q

When is Liminatus Pharma (NASDAQ:LIMN) reporting earnings?

A

Liminatus Pharma does not have any upcoming earnings scheduled.

Q

Is Liminatus Pharma (LIMN) going to split?

A

There is no upcoming split for Liminatus Pharma.

Q

What sector and industry does Liminatus Pharma (LIMN) operate in?

A

Liminatus Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.